If you have a HealthSpring or WellCare Medicare drug plan, you may have received a letter saying Jones Drug Store will not be in your plan’s pharmacy network starting January 1, 2027. We know that letter was unsettling. It reflects where things stand today, not where we expect them to end up. We are still in discussions, and we are hopeful an agreement will be reached.
What you need to know
- Nothing changes today. Keep filling your prescriptions with us as usual. Your coverage at Jones Drug Store stays the same through December 31, 2026.
- There is no need to transfer your prescriptions. Our goal is an agreement that keeps Jones Drug Store in your plan’s network for 2027.
- Jones Drug Store is not going anywhere. We will keep you informed.
- Medicare.gov and your plan’s pharmacy list may not show Jones Drug Store while discussions continue. That reflects today’s contract status, not a final decision.
- You can help. One short call to Medicare tells your plan that you want to keep your local pharmacy.
Where things stand
Jones Drug Store is in contract discussions with Express Scripts, the pharmacy benefit manager that administers prescription benefits for HealthSpring and Wellcare Medicare drug plans. Pharmacy benefit managers set the terms under which pharmacies are paid to fill prescriptions for a plan’s members.
We want to remain in the network, and that is what we are working toward. Our request is simple: terms that cover what it costs to buy your medicine and dispense it safely. We have not reached those terms yet, but the conversation is continuing and we are approaching it in good faith.
Discussions like this are common in health care, and they are often resolved before any change reaches patients. We believe this one can be too.
Why fair terms matter
We are asking for sustainable terms because the national picture shows what happens when local pharmacies do not have them.
- Closures have more than doubled. Nationwide, 3,929 pharmacies closed in 2025, compared with 1,764 in 2021, according to data presented to MedPAC, the commission that advises Congress on Medicare.
- Rural patients are affected most. One in three rural Medicare drug plan members lives in a ZIP code with no pharmacy at all (MedPAC, 2025 data).
- Closures affect health. Published research found that older adults whose pharmacy closes are less likely to keep taking their heart medications as prescribed.
How you can help
Medicare tracks feedback from its members and sends it to the plan for a response. If keeping your local pharmacy matters to you, one short call makes that known.
Call 1-800-MEDICARE (1-800-633-4227), available 24 hours a day, 7 days a week. TTY users call 1-877-486-2048. You can also file online at medicare.gov/my/medicare-complaint (choose “Prescription Drugs”).
Tell the representative you want to file a complaint about your Medicare drug plan’s pharmacy network, then share your own situation in your own words. Things patients often mention:
- You want to keep using Jones Drug Store and did not choose this change.
- You prefer not to receive your medications by mail, or have had problems with mail order.
- No other in-network pharmacy is convenient for you.
- You rely on services such as delivery, pill packaging, compounding, or medication synchronization.
Before you hang up, ask for a reference number and write it down. You may also file a grievance with your plan by calling the number on your ID card.
What happens next
We expect to have an update before the end of the year, and we will share it here, by mail, and in the pharmacy as soon as we know more. In the meantime, please keep filling your prescriptions with us as usual.
If you are reviewing your Medicare plan during open enrollment (through December 7), stop by or call. We can tell you which plans include Jones Drug Store and walk you through your options.
Thank you for standing with your local pharmacy. If you have questions, call us at 405-399-2277.
Sources
- MedPAC, “Preferred Networks and Pharmacy Access in Part D,” April 9, 2026
- NCPA summary of the Medicare Payment Advisory Commission meeting, April 21, 2026
- Qato et al., JAMA Network Open, 2019
- Federal Trade Commission settlement with Express Scripts, February 4, 2026
